Please assess the completion status of the following clinical trial:

Trial Title: Intrauterine Embryo Development With ANECOVA Device

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women age below 37~* Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH)~* Negative serologic screening for HIV, Hep B and C~* No uterine or ovarian alterations found by ultrasound~* Normal BMI (19 - 29 kg/m2).~Exclusion Criteria:~* At least 8 stage MII oocytes are not retrieved~* Endometriosis or PCO~* Severe male factor in the partner

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 36 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).